Trulieve Rings NYSE Closing Bell as First U.S. Cannabis Company on Big Board
Event summary
- Trulieve (NYSE: TRLV) rang the NYSE Closing Bell on August 18, 2026, marking its June 10, 2026, listing as the first U.S. cannabis company on the exchange.
- The company operates 207 medical dispensaries, employs over 5,000 people, and has 3.5M sq. ft. of cultivation capacity across four states.
- All Trulieve dispensaries were registered with the DEA following federal rescheduling of medical marijuana to Schedule III in April 2026.
- Trulieve generated $109M in cash flow from operations in H1 2026, ending Q2 with $325M in cash.
The big picture
Trulieve's NYSE listing and bell-ringing ceremony underscore the growing legitimacy of the U.S. cannabis industry. The company's scale and regulatory compliance position it as a potential consolidator in a fragmented market. Federal rescheduling and state expansions present both opportunities and execution challenges for Trulieve and its peers.
What we're watching
- Regulatory Tailwinds
- How federal rescheduling and state-level expansions will accelerate Trulieve's growth in Georgia and Texas.
- Market Positioning
- Whether Trulieve can maintain its leadership as more cannabis companies pursue NYSE listings.
- Financial Discipline
- The pace at which Trulieve converts its operational scale into sustained profitability.